A Single-arm Phase II Study of Alemtuzumab in Combination With High-dose Methylprednisolone in CLL Patients With p53 Deletion
Clinical trial NCT00292760 · COMPLETED
Trial details
- NCT number
- NCT00292760
- Sponsor
- Royal Marsden NHS Foundation Trust
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.